STUART PORTER: Open Payments
NPI 1689612996 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 43 payments from 10 companies in 2025. Trend: 2023 $439 · 2024 $995 · 2025 $802
Food & beverage: $802
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $381 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $135 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
| Collegium Pharmaceutical, Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| PFIZER INC. | 1 | $16 |
Products named: QULIPTA, CAPLYTA, UBRELVY, Qelbree, VRAYLAR, Jornay PM, TRINTELLIX, ZENPEP.
Industry payments across UT — which companies pay providers there.
